Literature DB >> 18533182

Histone H3K4me3 binding is required for the DNA repair and apoptotic activities of ING1 tumor suppressor.

P V Peña1, R A Hom, T Hung, H Lin, A J Kuo, R P C Wong, O M Subach, K S Champagne, R Zhao, V V Verkhusha, G Li, O Gozani, T G Kutateladze.   

Abstract

Inhibitor of growth 1 (ING1) is implicated in oncogenesis, DNA damage repair, and apoptosis. Mutations within the ING1 gene and altered expression levels of ING1 are found in multiple human cancers. Here, we show that both DNA repair and apoptotic activities of ING1 require the interaction of the C-terminal plant homeodomain (PHD) finger with histone H3 trimethylated at Lys4 (H3K4me3). The ING1 PHD finger recognizes methylated H3K4 but not other histone modifications as revealed by the peptide microarrays. The molecular mechanism of the histone recognition is elucidated based on a 2.1 A-resolution crystal structure of the PHD-H3K4me3 complex. The K4me3 occupies a deep hydrophobic pocket formed by the conserved Y212 and W235 residues that make cation-pi contacts with the trimethylammonium group. Both aromatic residues are essential in the H3K4me3 recognition, as substitution of these residues with Ala disrupts the interaction. Unlike the wild-type ING1, the W235A mutant, overexpressed in the stable clones of melanoma cells or in HT1080 cells, was unable to stimulate DNA repair after UV irradiation or promote DNA-damage-induced apoptosis, indicating that H3K4me3 binding is necessary for these biological functions of ING1. Furthermore, N216S, V218I, and G221V mutations, found in human malignancies, impair the ability of ING1 to associate with H3K4me3 or to induce nucleotide repair and cell death, linking the tumorigenic activity of ING1 with epigenetic regulation. Together, our findings reveal the critical role of the H3K4me3 interaction in mediating cellular responses to genotoxic stresses and offer new insight into the molecular mechanism underlying the tumor suppressive activity of ING1.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18533182      PMCID: PMC2576750          DOI: 10.1016/j.jmb.2008.04.061

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  51 in total

1.  UV induces nucleolar translocation of ING1 through two distinct nucleolar targeting sequences.

Authors:  M Scott; F M Boisvert; D Vieyra; R N Johnston; D P Bazett-Jones; K Riabowol
Journal:  Nucleic Acids Res       Date:  2001-05-15       Impact factor: 16.971

2.  Engineering a protein scaffold from a PHD finger.

Authors:  Ann H Y Kwan; David A Gell; Alexis Verger; Merlin Crossley; Jacqueline M Matthews; Joel P Mackay
Journal:  Structure       Date:  2003-07       Impact factor: 5.006

3.  The candidate tumor suppressor ING1b can stabilize p53 by disrupting the regulation of p53 by MDM2.

Authors:  Ka Man Leung; Lai See Po; Fan Cheung Tsang; Wai Yi Siu; Anita Lau; Horace T B Ho; Randy Y C Poon
Journal:  Cancer Res       Date:  2002-09-01       Impact factor: 12.701

4.  Role of the Sin3-histone deacetylase complex in growth regulation by the candidate tumor suppressor p33(ING1).

Authors:  A Kuzmichev; Y Zhang; H Erdjument-Bromage; P Tempst; D Reinberg
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

5.  Comparative assessment expression of the inhibitor of growth 1 gene (ING1) in normal and neoplastic tissues.

Authors:  Ghassan S Nouman; Brian Angus; John Lunec; Steve Crosier; Andrew Lodge; John J Anderson
Journal:  Hybrid Hybridomics       Date:  2002-02

6.  Genetic alterations of candidate tumor suppressor ING1 in human esophageal squamous cell cancer.

Authors:  L Chen; N Matsubara; T Yoshino; T Nagasaka; N Hoshizima; Y Shirakawa; Y Naomoto; H Isozaki; K Riabowol; N Tanaka
Journal:  Cancer Res       Date:  2001-06-01       Impact factor: 12.701

7.  Nuclear to cytoplasmic compartment shift of the p33ING1b tumour suppressor protein is associated with malignancy in melanocytic lesions.

Authors:  G S Nouman; J J Anderson; M E Mathers; N Leonard; S Crosier; J Lunec; B Angus
Journal:  Histopathology       Date:  2002-04       Impact factor: 5.087

8.  Loss of nuclear expression of the p33(ING1b) inhibitor of growth protein in childhood acute lymphoblastic leukaemia.

Authors:  G S Nouman; J J Anderson; K M Wood; J Lunec; A G Hall; M M Reid; B Angus
Journal:  J Clin Pathol       Date:  2002-08       Impact factor: 3.411

9.  The PHD finger of the chromatin-associated protein ING2 functions as a nuclear phosphoinositide receptor.

Authors:  Or Gozani; Philip Karuman; David R Jones; Dmitri Ivanov; James Cha; Alexey A Lugovskoy; Cheryl L Baird; Hong Zhu; Seth J Field; Stephen L Lessnick; Jennifer Villasenor; Bharat Mehrotra; Jian Chen; Vikram R Rao; Joan S Brugge; Colin G Ferguson; Bernard Payrastre; David G Myszka; Lewis C Cantley; Gerhard Wagner; Nullin Divecha; Glenn D Prestwich; Junying Yuan
Journal:  Cell       Date:  2003-07-11       Impact factor: 41.582

10.  Structural and functional conservation of the NuA4 histone acetyltransferase complex from yeast to humans.

Authors:  Yannick Doyon; William Selleck; William S Lane; Song Tan; Jacques Côté
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

View more
  63 in total

Review 1.  Keeping it in the family: diverse histone recognition by conserved structural folds.

Authors:  Kyoko L Yap; Ming-Ming Zhou
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-10-06       Impact factor: 8.250

Review 2.  The ING family tumor suppressors: from structure to function.

Authors:  Almass-Houd Aguissa-Touré; Ronald P C Wong; Gang Li
Journal:  Cell Mol Life Sci       Date:  2010-08-29       Impact factor: 9.261

Review 3.  Control of histone methylation and genome stability by PTIP.

Authors:  Ivan M Muñoz; John Rouse
Journal:  EMBO Rep       Date:  2009-02-20       Impact factor: 8.807

Review 4.  Histone methylation and aging: lessons learned from model systems.

Authors:  Brenna S McCauley; Weiwei Dang
Journal:  Biochim Biophys Acta       Date:  2014-05-21

5.  A role for H3K4 monomethylation in gene repression and partitioning of chromatin readers.

Authors:  Jemmie Cheng; Roy Blum; Christopher Bowman; Deqing Hu; Ali Shilatifard; Steven Shen; Brian D Dynlacht
Journal:  Mol Cell       Date:  2014-03-20       Impact factor: 17.970

6.  Structural and functional insights into the human Börjeson-Forssman-Lehmann syndrome-associated protein PHF6.

Authors:  Zhonghua Liu; Fudong Li; Ke Ruan; Jiahai Zhang; Yide Mei; Jihui Wu; Yunyu Shi
Journal:  J Biol Chem       Date:  2014-02-19       Impact factor: 5.157

7.  Inhibitor of growth 1 (ING1) acts at early steps of multiple DNA repair pathways.

Authors:  Julieta M Ceruti; María F Ogara; Camino Menéndez; Ignacio Palmero; Eduardo T Cánepa
Journal:  Mol Cell Biochem       Date:  2013-03-04       Impact factor: 3.396

Review 8.  ING proteins as potential anticancer drug targets.

Authors:  M Unoki; K Kumamoto; C C Harris
Journal:  Curr Drug Targets       Date:  2009-05       Impact factor: 3.465

Review 9.  Structural insight into histone recognition by the ING PHD fingers.

Authors:  Karen S Champagne; Tatiana G Kutateladze
Journal:  Curr Drug Targets       Date:  2009-05       Impact factor: 3.465

10.  A new bump in the epigenetic landscape.

Authors:  Anand S Bhagwat; Christopher R Vakoc
Journal:  Mol Cell       Date:  2014-03-20       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.